New hope for Australian leukaemia and lymphoma patients with key treatment option listed on PBS

A key new cancer treatment has just become more accessible for Australians fighting specific forms of leukaemia and lymphoma, thanks to the Morrison Government’s listing of Calquence® on the Pharmaceutical Benefits Scheme (PBS). On September 1, Calquence® (acalabrutinib) will be listed on the PBS for the first time for the treatment of chronic lymphocytic leukaemia…

Details

COVID-19: new funding for clinical trials

The Australian Government is providing $25 million for our best and brightest health and medical researchers to find breakthroughs in preventing and treating COVID-19. Research is a key weapon in the fight against COVID-19 – and this funding will help to ensure that Australian researchers are on the frontline of the fight. The Government will…

Details